Allogeneic Transplantation Using Mini-Conditioning for Treatment of Stage IV Breast Cancer

NCT00006261 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: therapeutic allogeneic lymphocytes
DRUG: cyclophosphamide
DRUG: docetaxel
DRUG: doxorubicin hydrochloride
DRUG: fludarabine phosphate
PROCEDURE: peripheral blood stem cell transplantation

Sponsor

Case Comprehensive Cancer Center

Collaborators

[object Object]